Jason Aldred
Inland Northwest Health Services(US)Neurology, Inc(US)Selkirk College(CA)
Publications by Year
Research Areas
Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Restless Legs Syndrome Research, Botulinum Toxin and Related Neurological Disorders, Autism Spectrum Disorder Research
Most-Cited Works
- → Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson’s disease(2022)237 cited
- → National randomized controlled trial of virtual house calls for Parkinson disease(2017)218 cited
- → Randomized phase I clinical trial of anti–α‐synuclein antibody BIIB054(2019)188 cited
- → Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial(2022)177 cited
- → The past, present, and future of telemedicine for Parkinson's disease(2014)175 cited
- → Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression(2021)152 cited
- →